GlassScriptPhysician profile
Ashish K Gupta
NPI 1942390729
$41,073.64
in general payments reported to CMS, 2019-2025
32 companies · $7,415 in 2025
The $7,415 reported for 2025 was more than what 88% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,456 · 2020: $1,290 · 2021: $2,057 · 2022: $2,761 · 2023: $1,125 · 2024: $24K · 2025: $7,415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $27K · Food and Beverage: $4,693 · Consulting Fee: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $27,416.67 |
| Food and Beverage | $4,693.13 |
| Consulting Fee | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $27,816.83 | 2021-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Cardiovascular Systems INC. | $2,744.26 | 2019-2023 | Diamondback Peripheral |
| Inari Medical, INC. | $1,383.37 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Lumenis Be INC | $1,088.48 | 2024 | M22 |
| Medtronic, INC. | $1,029.79 | 2021-2025 | Venaseal, Closurefast |
| Silk Road Medical, INC. | $1,027.03 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $744.80 | 2019-2025 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System, Enroute .014" Guidewire |
| Stryker Corporation | $637.15 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Artix Mt |
| Philips North America LLC | $600.61 | 2021-2024 | (6554) Peripheral Vascular Undivided, (6577) Visions 014 |
| Cook Medical LLC | $580.64 | 2019-2022 | |
| Cook Incorporated | $559.14 | 2021 | |
| Abbott Laboratories | $363.24 | 2023-2025 | Diamondback Peripheral, Esprit, Amplatzer |
| Endologix LLC | $308.90 | 2023-2024 | Alto Abdominal Stent Graft System |
| Penumbra, INC. | $288.77 | 2019-2025 | Indigo System, Ruby Coil |
| Bard Peripheral Vascular, INC. | $258.56 | 2022-2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $217.26 | 2021-2024 | Jardiance |
| Medtronic Vascular, INC. | $213.88 | 2019-2020 | |
| Vesper Medical | $194.97 | 2021-2022 | |
| Shockwave Medical, INC | $192.91 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cordis US Corp. | $148.55 | 2022 | |
| W. L. Gore & Associates, INC. | $146.92 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2022 | |
| Organogenesis INC. | $102.04 | 2022 | |
| Lemaitre Vascular, INC. | $59.19 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $53.49 | 2022 | |
| Cardinal Health 200 LLC | $45.88 | 2020 | |
| Cardiva Medical, INC. | $35.29 | 2022 | |
| Acist Medical Systems, INC. | $27.37 | 2020 | |
| Fujifilm Healthcare Americas Corporation | $24.24 | 2021 | |
| Bioventus LLC | $20.78 | 2022 | |
| Sanara Medtech INC. | $20.16 | 2022 | |
| Tactile Systems Technology INC | $14.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.